CA2708723A1 - Formes solides de sels de varenicline et procedes pour leur preparation - Google Patents

Formes solides de sels de varenicline et procedes pour leur preparation Download PDF

Info

Publication number
CA2708723A1
CA2708723A1 CA2708723A CA2708723A CA2708723A1 CA 2708723 A1 CA2708723 A1 CA 2708723A1 CA 2708723 A CA2708723 A CA 2708723A CA 2708723 A CA2708723 A CA 2708723A CA 2708723 A1 CA2708723 A1 CA 2708723A1
Authority
CA
Canada
Prior art keywords
varenicline
mesylate
mixture
ppm
sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2708723A
Other languages
English (en)
Inventor
Maytal Piran
Vinod Kumar Kansal
Suhail Ahmad
Vineet Kumar Tyagi
Ayyagari Subramanya Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Priority claimed from PCT/US2010/039446 external-priority patent/WO2010151524A1/fr
Publication of CA2708723A1 publication Critical patent/CA2708723A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention concerne des sels et des formes cristallines de plusieurs sels de Varénicline, à savoir, sulfate de Varénicline, mésylate de Varénicline, et fumarate de Varénicline, des procédés de préparation de formes solides de sulfate de Varénicline, mésylate de Varénicline, et fumarate de Varénicline, et des procédés de préparation d'une base Varénicline à partir desdits sels de Varénicline.
CA2708723A 2009-06-22 2010-06-22 Formes solides de sels de varenicline et procedes pour leur preparation Abandoned CA2708723A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21909909P 2009-06-22 2009-06-22
US61/219,099 2009-06-22
US34530010P 2010-05-17 2010-05-17
US61/345,300 2010-05-17
PCT/US2010/039446 WO2010151524A1 (fr) 2009-06-22 2010-06-22 Formes solides des sels de varénicline et leurs procédés de préparation

Publications (1)

Publication Number Publication Date
CA2708723A1 true CA2708723A1 (fr) 2010-12-22

Family

ID=43379109

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2708723A Abandoned CA2708723A1 (fr) 2009-06-22 2010-06-22 Formes solides de sels de varenicline et procedes pour leur preparation

Country Status (1)

Country Link
CA (1) CA2708723A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011110954A1 (fr) * 2010-03-09 2011-09-15 Actavis Group Ptc Ehf Varénicline de haute pureté ou son sel pharmaceutiquement acceptable sensiblement exempt d'impureté méthylvarénicline

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011110954A1 (fr) * 2010-03-09 2011-09-15 Actavis Group Ptc Ehf Varénicline de haute pureté ou son sel pharmaceutiquement acceptable sensiblement exempt d'impureté méthylvarénicline

Similar Documents

Publication Publication Date Title
EP1392307B1 (fr) Sels de tartrate de 5,8,14-triazatetracyclo 10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
AU2002253482A1 (en) Tartrate salts of 5,8,14-triazatetracyclo (10.3.102,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
CA2709774C (fr) Tosylate de varenicline, un intermediaire dans le procede de preparation du l-tartrate de varenicline
KR20110135397A (ko) 시타글립틴 염의 고체 상태 형태
EP1390366B1 (fr) Sel citrate de 5, 8, 14-triazatetracyclo(10.3.1.0?2,11 .0?4,9 )-hexadeca-2.(11),3,5,7,9-pentaene
EP2729470B1 (fr) (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dhydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine cristallin
KR20190130128A (ko) Ag-10, 이의 중간체, 및 이의 염을 제조하는 방법
KR20070110128A (ko) 퀴누클리딘 유도체의 신규한 염
US8178537B2 (en) Solid state forms of varenicline salts and processes for preparation thereof
CA2708723A1 (fr) Formes solides de sels de varenicline et procedes pour leur preparation
US8299258B2 (en) Method of making piperidine derivatives
KR100572430B1 (ko) 치료적 화합물의 시트르산 염 및 그의 약제학적 조성물
US20240279228A1 (en) Novel salts and crystals
US20230133435A1 (en) Cocrystals derivatives of apixaban
WO2011140431A1 (fr) Sels de la varénicline et leurs formes cristallines
WO2021083554A1 (fr) 3-((r)-2-(amino-2-phényléthyl)-1-(2-fluoro-6-trifluorométhylbenzyl)-5-iodo-6-méthyl-1h-pyrimidine-2,4-dione ou un sel de celle-ci, procédé pour sa préparation, et son utilisation dans la synthèse d'élagolix
EP2154137A1 (fr) Formule cristalline à base de moxifloxacine
AU2002255219A1 (en) The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11,04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130625